Prosthetic Heart Valve Market | Asia Pacific registering a CAGR of 13.1 % by 2030

Prosthetic Heart Valve Market

Prosthetic Heart Valve Market Expected to Reach $19.7 Billion by 2031—Allied Market Research

PORTLAND, OREGON, UNITED STATE, July 29, 2022 /EINPresswire.com/ -- According to a new report published by Allied Market Research, titled, “Prosthetic Heart Valve Market," The prosthetic heart valve market size was valued at $6.9 billion in 2021, and is estimated to reach $19.7 billion by 2031, growing at a CAGR of 11.1% from 2022 to 2031.

An artificial heart valve, also known as a prosthetic heart valve, is inserted in the heart of someone who has cardiac vascular disease (valvular heart disease). A strong material such as carbon or titanium is used to construct the prosthetic valve. Mechanical heart valves, transcatheter heart valves, and tissue or bio-prosthetic heart valves are the three forms of prosthetic heart valves. Individuals have the option of picking a prosthesis based on their health state and the advice of their surgeon. The heart valve replacement method allows the diseased valve to be removed and replaced with an artificial valve.

Get Sample Report at: (Flash Sale Tell 20th August 2022):

https://www.alliedmarketresearch.com/request-sample/2176

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the market along with the current prosthetic heart valve market trends and future estimations to explain the imminent investment pockets.
A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
Comprehensive quantitative analysis of the prosthetic heart valve industry from 2022 to 2031 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps to understand the application and products of coronary stents used across the globe.
Key market players and their strategies have been analyzed to understand the competitive outlook of the market.
Depending on product, the transcatheter heart valve held the largest share in the global market in 2021.
Region wise, Asia Pacific is expected to experience growth at the highest rate, registering a CAGR of 13.1% during the forecast period.

Coronavirus is a large family of severely acute respiratory syndrome (SARS) viruses that causes diseases ranging from common cold to severe respiratory diseases. The implementation of lockdown delayed the surgical procedure needed for installing prosthetic heart valve and manufacturing of prosthetic heart valve up to six months, thereby having a minimal negative impact on the market. However, the demand of prosthetic heart valve arose as the population that suffered with virus experienced asthma and cardiovascular disorders as an after effect of the contamination that led to gradual growth of the market, and is a major factor that still drives the growth of the prosthetic heart valve market.

The prosthetic heart valve market is segmented into product type and by region. By product type, the market is segregated into mechanical heart valve, tissue heart valve, and transcatheter heart valve. The tissue heart valve segment is further segmented in stented tissue heart valve and stentless tissue heart valve. The transcatheter heart valve segment dominated the market in 2021, and is anticipated to continue this trend during the forecast period, owing to rise in prevalence of cardiac disorders and surge in demand for cardiac valve replacement therapies.

 Key Market Segments

By Product
Mechanical Heart Valve
Tissue Heart Valve
Stented Tissue Heart Valve
Stentless Tissue Heart Valve
Transcatheter Heart Valve

By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe

 Key Market Players

Abbott
Medtronic
MERIL LIFESCIENCES
Boston Scientific Corporation
Micro Interventional Devices, Inc.
Direct Flow medical, Inc.
Edwards Lifesciences Corporation
LivaNova PLC.
JenaValve Technology, Inc.
CryoLife, Inc.

Ask to Our Industry Expert: (Flash Sale Tell 20th August 2022):

https://www.alliedmarketresearch.com/purchase-enquiry/2176

The major factors that impact the growth of prosthetic heart valve market include high prevalence of valvular heart disease (VHD). For instance, according to the estimations of the U.S. Department of Health & Human Services, around 2.5% of the U.S. population is suffering from valvular heart disease (VHD) and large proportion of these patients are older adults. Regulatory approval for heart valves, incorporation of technology improvements, and increase in the number of heart valve implantation procedures are further driving the demand for prosthetic heart valves. One of the key reasons for a global preference for prosthetic heart valves is that they are an effective alternative to invasive open heart surgery. However, high costs associated with transcatheter heart valve devices, procedure-related risks & problems, and product recalls are some of the limitations that are projected to hamper the global prosthetic heart valve market growth.

We also Offers Regional and Country Reports-

Japan Prosthetic Heart Valve Market
South Korea Prosthetic Heart Valve Market
Singapore Prosthetic Heart Valve Market
China Prosthetic Heart Valve Market
Indonesia Prosthetic Heart Valve Market
Australia Prosthetic Heart Valve Market
Taiwan Prosthetic Heart Valve Market

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬

Bleeding Disorders Treatment Market

Corneal Pachymetry Market

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

David Correa
Allied Analytics LLP
800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.